Successful Treatment with CAR- T Cells in a Patient with Immune Thrombocytopenia Associated with Castleman Disease
Journal Title: Diseases & Research - Year 2022, Vol 2, Issue 1
Abstract
Multicentric Castleman disease (MCD), a rare lymphoproliferative disorder of incompletely understood etiology, is manifested as enlarged multiple lymph node and multiple organs involvement. The best therapeutic option for this disease remains unknown. A 21-year-old male patient of MCD with swilling lymph nodes received combination chemotherapy treatment with unsatisfactory efficacy. He developed thrombocytopenia during disease progression and failed steroid treatment. His platelet increased to normal level on day 27 of receiving infusion of humanised anti-CD19 chimeric antigen receptor (CAR) T cells (1 × 106 cells/kg) and murine anti-BCMA CAR T cells (0.6 × 106 cells/kg). He has a stable platelet count and no evidence of progression of lymphadenopathy for 45 months at this writing. This case report reminds clinicians to be aware of the potential clinical value of CAR T cells therapy in MCD.
Authors and Affiliations
Xiaotian Zhang, Hai Cheng
Keywords
Related Articles
- EP ID EP740158
- DOI 10.54457/DR.202201003
- Views 30
- Downloads 0
Determination of mRNA Targets of miR-376c within the RNA-Induced Silencing Complex
Background The focus of the present study was to establish an easy combined method based on the MirTrap system together with a mRNA array to efficiently define target mRNAs which can be bound by miR-376 within the RNA-in...
Salvage Therapy with Gilteritinib Plus Venetoclax for FLT3-ITD-Positive AML: A Case Report and Literature Review
FMS-like tyrosine kinase 3 (FLT3) mutations occur in around 30% of patients in acute myeloid leukemia (AML), and are generally associated with unfavorable outcomes. Gilteritinib is a highly specific second-generation cla...
Role of Various Immune Cells in the Tumor Microenvironment
The tumor microenvironment (TME) has numerous promotive and suppressive effects on tumor growth. The TME harbors adaptive and innate immune cells such as T cells, B cells, natural killer (NK) cells, macrophages, neutroph...
Successful Treatment with CAR- T Cells in a Patient with Immune Thrombocytopenia Associated with Castleman Disease
Multicentric Castleman disease (MCD), a rare lymphoproliferative disorder of incompletely understood etiology, is manifested as enlarged multiple lymph node and multiple organs involvement. The best therapeutic option fo...
Review on Tumour Microenvironment Cell Types Associated with Metastatic Cancer
The Tumour microenvironment (TME) is a highly dynamic and perpetually altering entity of cancer development, progression, invasion, and dissemination. TME is interspersed with cellular components such as immune cells, bl...